Please login to the form below
Amgen adds to oncology pipeline with $1.9bn Five Prime Therapeutics acquisition
Five Prime's pipeline includes potentially first-in-class anti-FGFR2b antibody bemarituzumab
GSK, Vir halt enrolment of phase 3 COVID-19 antibody study
Move comes after recommendation from independent data and safety monitoring board
Germany backs use of AZ/Oxford COVID-19 vaccine in over-65s
Country's Health Ministry also recommended extending gap between doses to 12 weeks
CureVac signs manufacturing agreement with Novartis for COVID-19 vaccine candidate
Novartis will aid manufacturing for up to 50 million doses of CureVac's vaccine in 2021
EMA begins rolling review process for Sputnik V COVID-19 vaccine
Late-stage trial results found vaccine gives 91.6% protection against COVID-19
Pfizer’s ALK inhibitor Lorbrena scores expanded FDA approval for first-line NSCLC
The European Medicines Agency is also reviewing an application for the drug
MHRA to fast-track vaccines modified for new COVID-19 variants
Pfizer, Moderna and AstraZeneca are all working on modified vaccines
Novavax seeks FDA emergency approval for COVID-19 vaccine by May
Company is hoping FDA will review data from a UK-based trial
AbbVie buys exclusive right to acquire Mitokinin’s Parkinson’s asset
Company can acquire asset following the completion of IND enabling studies
Q&A: Emily Spilko
PME interviews Evoke's Executive Creative Director
-
Q&A: Louise SharpPME interviews Makara Health's owner and managing director
-
Q&A: Shairose EbrahimPME interviews integrated medhealth communication (imc) group's President and CEO
-
Merck & Co to help produce J&J’s COVID-19 vaccine in the USCompany has signed agreements to bolster vaccine manufacturing capacity
-
First shipments of AZ/Oxford COVID-19 vaccine sent through COVAXFirst COVAX shipments of vaccine dispatched to Ghana and Cote D’Ivoire
-
UK study finds Pfizer/BioNTech, AZ/Oxford vaccines reduce severe COVID-19 in older peopleData suggests vaccine is 80% effective at preventing hospitalisations in over-80s
-
Merck KGaA gains exclusive rights to Debiopharma’s late-stage oncology assetDevelopment and commercialisation deal could be worth up to $1.08bn
-
MSD withdraws Keytruda’s US indication for small cell lung cancerCheckpoint inhibitor gained accelerated approval in 2019
-
AZ sells stake in Moderna for around $1.2bnAs Moderna expects COVID-19 vaccine sales to reach $18.4bn this year
-
AZ, Amgen’s tezepelumab reduces asthma exacerbations in broad patient populationDetailed results from the NAVIGATOR trial presented at virtual AAAAI meeting
Latest appointments
-
Syneos Health Communications announces senior hires to Europe-based teamNew hires bolster market access, scientific and medical and creative capabilities
-
Evoke KYNE promotes Michael Grela to head of reputation and social impactNewly established role creates new in-house speciality area at agency
-
Dan Carucci becomes global chief medical officer of McCann HealthCarucci initially joined McCann in February 2018 as medical director
-
Genmab appoints Tahamtan Ahmadi as chief medical officer, head of experimental medicinesAhmadi joined Genmab in 2017, previously serving as senior vice president, head of oncology
-
Havas Just:: names Nicole Yost chief executive officerYost will replace Jennie Talman, who is stepping aside after 15 years
COVID-19 Updates and Daily News
Featured jobs
- Senior Account Director - Med Comms Agency
-
Salary TBC
-
MEDICAL WRITER - HOME WORKING
-
Salary TBC
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- ACCOUNT MANAGER / SENIOR ACCOUNT MANAGER
-
Salary TBC
-
SENIOR MEDICAL WRITER
-
Salary TBC
- STEM Healthcare founder Rob Wood secures a 25% stake in performance-io
- Sinopharm’s COVID-19 vaccine scores approval in China
- FDA authorises flexible storage for Pfizer/BioNTech COVID-19 vaccine
- UK study finds Pfizer/BioNTech, AZ/Oxford vaccines reduce severe COVID-19 in older people
- AZ/Oxford University vaccine shows 82.4% efficacy with extended dosing schedule
- Roche, Genentech partner with The Weill Neurohub on ten-year neuroscience collaboration
- Amgen adds to oncology pipeline with $1.9bn Five Prime Therapeutics acquisition
- GSK, Vir halt enrolment of phase 3 COVID-19 antibody study
- Germany backs use of AZ/Oxford COVID-19 vaccine in over-65s
- CureVac signs manufacturing agreement with Novartis for COVID-19 vaccine candidate
- #DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
- Gene Editing and Precision Medicine: The Future of Healthcare?
PMHub
claire@dovetailstrategies.com
About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...
Latest intelligence
- #DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
- Women are largely prescribed exactly the same treatment regimens as men, with no account for the underlying differences in physiology and drug metabolism between the sexes....
- Good design saves lives
- Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
- Why you must understand the pricing of patient recruitment companies
- Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...
Quick links
Infographics
